CBR/CMR therapy(Hemogenyx)

N/A

Report date: 2024/12/09 10:09:25

Base Information

Drug NameCBR/CMR therapy(Hemogenyx)

Drug Alias NameChimeric Bait Receptor Platform therapy(Hemogenyx)Chimeric Macrophage Receptor Platform therapy(Hemogenyx)

ClassificationCell and gene therapy > Gene therapyCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy

Mechanisms of ActionT lymphocyte replacementsImmunologic cytotoxicity

TargetsNot applicable

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesHemogenyx Pharmaceuticals PLC

China Registration ClassN/A

Develop Information

Active CompaniesHemogenyx Pharmaceuticals PLC

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A